Clinical Trial Update: Disulfiram and Cisplatin in Refractory TGCTs. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating disulfiram in combination with cisplatin for refractory germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor

Drugs mentioned

• CISPLATIN (cisplatin)
• Disulfiram (Disulfiram)

Snippet

Sponsor: National Cancer Institute, Slovakia | Conditions: Germ Cell Tumor | Phase 2 | Status: COMPLETED